Interference with the lower gut-liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis

3Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

The gut-liver axis describes the complex interactions between gut microbiota, the small and large bowel, the immune system and the liver. Current evidence associates abnormalities within the gut-liver axis with liver disease such as primary sclerosing cholangitis (PSC). PSC is believed to be an immune-mediated disease though the exact mechanism of its pathogenesis remains unknown. Here, we report a case of a 66 -year-old woman with treatment-resistant ulcerative colitis and PSC which continued to be active following subtotal colectomy. Interestingly, her PSC achieved full remission after proctectomy for treatment-resistant proctitis in the rectal stump. This case report supports existing hypotheses that PSC is an immune-mediated disease triggered by antigens within the gut. More notably, it suggests the yet unidentified pathogens may be localised to the lower gastrointestinal tract including the rectum.

Cite

CITATION STYLE

APA

Ong, J., Mebarek, L., Bath, M., Swift, C., Javaid, B., Patel, J., & Al-Naeeb, Y. (2018). Interference with the lower gut-liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis. BMJ Open Gastroenterology, 5(1). https://doi.org/10.1136/bmjgast-2018-000239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free